Semi Daonil 2.5 mg Tablet is a reliable oral medication crafted to manage type 2 diabetes mellitus in adults. Containing Glibenclamide (2.5 mg), a sulfonylurea, this tablet stimulates insulin release from the pancreas to effectively lower blood sugar levels. Manufactured by Sanofi India Ltd., a trusted name in pharmaceuticals, Semi Daonil is designed for individuals whose blood glucose cannot be controlled by diet and exercise alone. Offering a low-dose option, it’s an affordable and potent choice to help maintain glycemic control and reduce the risk of diabetes-related complications.

Key Features

• Active Ingredient: Glibenclamide (2.5 mg), a second-generation sulfonylurea.
• Purpose: Lowers blood sugar in type 2 diabetes by enhancing insulin secretion, supporting better glucose management.
• Packaging: Available in strips of 10 white, hexagonal tablets, scored for easy splitting if needed, ensuring convenience and precise dosing.
• Quality Assurance: Produced under strict Good Manufacturing Practices (GMP) for consistent safety and efficacy.

Benefits

• Effective Blood Sugar Control: Stimulates pancreatic beta cells to release insulin, tackling high glucose levels after meals and during fasting.
• Low-Dose Flexibility: At 2.5 mg, it’s ideal for starting treatment or fine-tuning therapy, minimizing the risk of overcorrection.
• Affordable Option: Provides proven diabetes management at a budget-friendly price, broadening access to essential care.
• Complementary Support: Works best alongside a balanced diet and exercise, amplifying lifestyle efforts for stable glucose levels.

How It Works
Semi Daonil’s Glibenclamide targets the pancreas, binding to specific receptors on beta cells to boost insulin production. This insulin surge helps move glucose from the bloodstream into cells for energy, reducing circulating sugar levels. It’s particularly effective for post-meal spikes, making it a staple in type 2 diabetes care when the body still produces some insulin naturally.

Dosage and Administration

• Recommended Dose: Typically one 2.5 mg tablet daily, taken with breakfast or the first main meal, as prescribed by your doctor. Dosage may increase based on response—max 15 mg/day.
• Instructions: Swallow whole or split (if directed) with water, ideally just before eating to align with insulin release and food intake.
• Note: Follow your doctor’s guidance closely—adjustments depend on blood sugar monitoring. If you miss a dose, take it with your next meal unless it’s time for the next one—don’t double up.

Safety Information

• Side Effects: Common effects include mild hypoglycemia (shakiness, sweating), weight gain, or digestive upset (nausea, stomach pain). Rare but serious risks like severe low blood sugar or allergic reactions (rash, itching) need prompt medical attention.
• Precautions: Not for type 1 diabetes, diabetic ketoacidosis, or severe liver/kidney disease. Avoid if allergic to sulfonylureas. Use cautiously in elderly patients or with alcohol (heightens hypoglycemia risk). Not recommended during pregnancy/breastfeeding—insulin is preferred.
• Warnings: Monitor blood sugar regularly hypoglycemia can occur, especially if meals are skipped or with intense exercise. Avoid driving if dizzy or shaky.
• Storage: Store below 25°C (77°F) in a dry place, away from heat, moisture, and children.

Why Choose Semi Daonil 2.5 mg Tablet?
Semi Daonil 2.5 mg offers a practical, low-dose approach to type 2 diabetes management, blending efficacy with affordability. Backed by Sanofi’s pharmaceutical expertise, it’s a dependable choice for those needing a nudge in insulin production without the complexity of injections. Its scored design and simple dosing make it user-friendly, empowering you to take control of your health alongside lifestyle tweaks.